يعرض 1 - 10 نتائج من 17 نتيجة بحث عن '"MESH : Antigens, CD44"', وقت الاستعلام: 1.44s تنقيح النتائج
  1. 1

    المساهمون: Centre d'Immunologie de Marseille - Luminy (CIML), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: European Journal of Immunology
    European Journal of Immunology, Wiley-VCH Verlag, 2011, 41 (8), pp.2414-23. ⟨10.1002/eji.201141494⟩
    European Journal of Immunology, 2011, 41 (8), pp.2414-23. ⟨10.1002/eji.201141494⟩

  2. 2

    المساهمون: Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Section Génétique - Groupe Prédispositions génétiques au cancer, Centre International de Recherche contre le Cancer (CIRC), Equipe 7, Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), equipe 2, Institut Universitaire de France (IUF), Ministère de l'Education nationale, de l’Enseignement supérieur et de la Recherche (M.E.N.E.S.R.)-Ministère de l'Education nationale, de l’Enseignement supérieur et de la Recherche (M.E.N.E.S.R.)-Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Scanella, Marie-Pierre

    المصدر: Epigenetics
    Epigenetics, Taylor & Francis, 2011, 6 (4), pp.428-39

  3. 3

    المساهمون: Physico-chimie, pharmacotechnie, biopharmacie (PCPB), Université Paris-Sud - Paris 11 (UP11)-Centre National de la Recherche Scientifique (CNRS), Neuropsychopharmacologie des addictions. Vulnérabilité et variabilité expérimentale et clinique (NAVVEC - UM 81 (UMR 8206/ U705)), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)-Institut des sciences du Médicament -Toxicologie - Chimie - Environnement (IFR71), Institut National de la Santé et de la Recherche Médicale (INSERM)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5)-Université Paris Diderot - Paris 7 (UPD7), Institut des sciences du végétal (ISV), Centre National de la Recherche Scientifique (CNRS), IFR 141, Institut National de la Santé et de la Recherche Médicale (INSERM)-Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL (ENSCP)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL (ENSCP)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Université Paris Descartes - Paris 5 (UPD5)-Université Paris Diderot - Paris 7 (UPD7), Physico-chimie, pharmacotechnie, biopharmacie ( PCPB ), Université Paris-Sud - Paris 11 ( UP11 ) -Centre National de la Recherche Scientifique ( CNRS ), Neuropsychopharmacologie des addictions. Vulnérabilité et variabilité expérimentale et clinique ( NAVVEC (UM 81) ), Université Paris Diderot - Paris 7 ( UPD7 ) -Institut des sciences du Médicament -Toxicologie - Chimie - Environnement ( IFR71 ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL ( ENSCP ) -Centre National de la Recherche Scientifique ( CNRS ) -Institut de Recherche pour le Développement ( IRD ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL ( ENSCP ) -Centre National de la Recherche Scientifique ( CNRS ) -Institut de Recherche pour le Développement ( IRD ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Institut des sciences du végétal ( ISV ), Centre National de la Recherche Scientifique ( CNRS )

    المصدر: Journal of Controlled Release
    Journal of Controlled Release, Elsevier, 2012, 162 (3), pp.545-52. ⟨10.1016/j.jconrel.2012.07.015⟩
    Journal of Controlled Release, Elsevier, 2012, 162 (3), pp.545-52. 〈10.1016/j.jconrel.2012.07.015〉

  4. 4

    المساهمون: Centre méditérannéen de médecine moléculaire (C3M), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10, Signalisation moléculaire et obésité, COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-IFR50-Institut National de la Santé et de la Recherche Médicale (INSERM), Transduction du Signal : Signalisation Calcique et Phosphorylation, Université Joseph Fourier - Grenoble 1 (UJF)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Génétique, physiopathologie et ingénierie du tissu osseux (GéPITOS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA), Centre de Recherche des Cordeliers (CRC (UMR_S 872)), Université Paris Descartes - Paris 5 (UPD5)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), University of Oxford [Oxford], Environnement et Grandes Cultures (EGC), Institut National de la Recherche Agronomique (INRA)-AgroParisTech, Service de Chirurgie Digestive et Transplantation Hépatique, Hôpital Archet II, Digestive Center, Centre Hospitalier Universitaire de Nice (CHU Nice), Université Côte d'Azur (UCA)-Université Côte d'Azur (UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université Côte d'Azur (UCA)-Université Côte d'Azur (UCA)-IFR50-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Côte d'Azur (UCA)-Université Côte d'Azur (UCA)-Centre National de la Recherche Scientifique (CNRS), Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), AgroParisTech-Institut National de la Recherche Agronomique (INRA), Centre méditérannéen de médecine moléculaire ( C3M ), Université Nice Sophia Antipolis ( UNS ), Université Côte d'Azur ( UCA ) -Université Côte d'Azur ( UCA ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Institut Mondor de Recherche Biomédicale ( IMRB ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 ( UPEC UP12 ), Université Côte d'Azur ( UCA ) -Université Côte d'Azur ( UCA ) -IFR50-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Joseph Fourier - Grenoble 1 ( UJF ) -Commissariat à l'énergie atomique et aux énergies alternatives ( CEA ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Génétique, physiopathologie et ingénierie du tissu osseux ( GéPITOS ), Université Côte d'Azur ( UCA ) -Université Côte d'Azur ( UCA ) -Centre National de la Recherche Scientifique ( CNRS ), Centre de Recherche des Cordeliers ( CRC (UMR_S 872) ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Oxford Centre for Diabetes, Endocrinology and Metabolism ( OCDEM ), Environnement et Grandes Cultures ( EGC ), AgroParisTech-Institut National de la Recherche Agronomique ( INRA ), Epidémiologie et écologie des maladies animales ( Epidémiologie ), Centre de Coopération Internationale en Recherche Agronomique pour le Développement ( CIRAD ), CHU Nice, Université Nice Sophia Antipolis (1965 - 2019) (UNS), University of Oxford, Service de Chirurgie Digestive / Centre de Transplantation Hépatique [CHU Nice]

    المصدر: Diabetes
    Diabetes, American Diabetes Association, 2009, 58 (1), pp.125-33. ⟨10.2337/db08-0400⟩
    Diabetes, American Diabetes Association, 2009, 58 (1), pp.125-33. 〈10.2337/db08-0400〉
    Diabetes, 2009, 58 (1), pp.125-33. ⟨10.2337/db08-0400⟩

    مصطلحات موضوعية: Male, MESH : RNA, Messenger, Endocrinology, Diabetes and Metabolism, Mice, 0302 clinical medicine, MESH : Oleic Acid, MESH: Animals, Osteopontin, MESH : Immunoblotting, MESH : Macrophages, Liver injury, 0303 health sciences, Tumor, MESH: Middle Aged, MESH: Immunoblotting, MESH : Reverse Transcriptase Polymerase Chain Reaction, Obesity, Morbid, Hyaluronan Receptors, Adipose Tissue, Tumor necrosis factor alpha, MESH: Adipose Tissue, medicine.medical_specialty, MESH: Gene Expression, MESH: Antigens, CD44, MESH : Adipose Tissue, 03 medical and health sciences, MESH: Weight Loss, Humans, MESH : Middle Aged, RNA, Messenger, [ SDV.BBM ] Life Sciences [q-bio]/Biochemistry, Molecular Biology, MESH: Humans, Tumor Necrosis Factor-alpha, Macrophages, MESH : Humans, MESH: Oleic Acid, MESH: Adult, medicine.disease, Mice, Inbred C57BL, MESH : Gene Expression, Endocrinology, MESH: Tumor Necrosis Factor-alpha, MESH: Female, MESH: Liver, MESH : Fatty Liver, MESH: Osteopontin, Messenger, Adipose tissue, Gene Expression, Inbred C57BL, MESH: Reverse Transcriptase Polymerase Chain Reaction, MESH : Antigens, CD44, MESH : Female, MESH : Osteopontin, CD44, Morbid, Receptor, MESH: Fatty Liver, MESH : Tumor Necrosis Factor-alpha, biology, Reverse Transcriptase Polymerase Chain Reaction, Fatty liver, MESH : Adult, Middle Aged, Liver, Female, Obesity Studies, Adult, MESH : Obesity, Morbid, MESH: Cell Line, Tumor, MESH : Male, Immunoblotting, 030209 endocrinology & metabolism, MESH : Mice, Inbred C57BL, Cell Line, Insulin resistance, stomatognathic system, MESH: Mice, Inbred C57BL, Cell Line, Tumor, Internal medicine, MESH : Mice, Weight Loss, Internal Medicine, medicine, Animals, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, Obesity, Antigens, MESH: Mice, 030304 developmental biology, MESH: RNA, Messenger, MESH : Cell Line, Tumor, MESH : Liver, MESH: Macrophages, MESH: Obesity, Morbid, MESH: Male, Fatty Liver, biology.protein, RNA, MESH : Animals, MESH : Weight Loss, Steatosis, Oleic Acid

  5. 5

    المساهمون: Developpement Normal et Pathologique du Système Immunitaire, Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Généthon, Développement des Lymphocytes, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Histologie-Embryologie et Cytogénétique Assistance Publique, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service d'Anatomie et Cytologie Pathologique, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-CHU Necker - Enfants Malades [AP-HP], Cellectis SA, CELLECTIS, Virologie moléculaire et Vectorologie, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Unité d'Immunologie et Hématologie Pédiatrique, Service d'Hématologie, Département de Biothérapie [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5), This work was funded by grants from Institut National de la Santé et de la Recherche (INSERM), the Association Française contre les Myopathies (AFM) contract GAT0203, the Consortium National de Recherche en Génomique, the EC contract QLK3-CT-1999-00859, the Consert contract no. 005242, the Inherinet contract QLK3-CT-2001-00427, the Agence Nationale de la Recherche grant 05-MRAR-004, and a grant from Amgen-France (M. de Garidel and C. Cailliot). F.B.'s fellowship was provided by the AFM. P.S.S. was supported by INSERM, Electricité de France, and the Fondation Singer Polignac. J.H. is a fellow of the Deutsche Akademie der Naturforscher Leopoldina (BMBF-LPD 9901/8-149), Immunologie moléculaire et biothérapies innovantes (IMBI), École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université d'Évry-Val-d'Essonne (UEVE)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Généthon, Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Genethon, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Assistance publique - Hôpitaux de Paris (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Descartes - Paris 5 ( UPD5 ) -CHU Necker - Enfants Malades [AP-HP], Institut Pasteur [Paris]-Centre National de la Recherche Scientifique ( CNRS ), Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Descartes - Paris 5 (UPD5)-CHU Necker - Enfants Malades [AP-HP], CHU Necker - Enfants Malades [AP-HP]-Université Paris Descartes - Paris 5 (UPD5)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)

    المصدر: Molecular Therapy
    Molecular Therapy, Cell Press, 2008, 16 (8), pp.1490-9. ⟨10.1038/mt.2008.118⟩
    Molecular Therapy, 2008, 16 (8), pp.1490-1499. ⟨10.1038/mt.2008.118⟩
    Molecular Therapy, Nature Publishing Group, 2008, 16 (8), pp.1490-9. 〈10.1038/mt.2008.118〉
    Molecular Therapy, 2008, 16 (8), pp.1490-9. ⟨10.1038/mt.2008.118⟩
    Molecular Therapy, Nature Publishing Group, 2008, 16 (8), pp.1490-9. ⟨10.1038/mt.2008.118⟩

    مصطلحات موضوعية: Male, CD3 Complex, MESH: Antigens, CD3, Genetic enhancement, T-Lymphocytes, MESH: Interleukin-2 Receptor alpha Subunit, MESH: Antigens, CD4, MESH: Flow Cytometry, MESH: Mice, Knockout, MESH: Hematopoietic Stem Cells, Mice, 0302 clinical medicine, [ SDV.MP ] Life Sciences [q-bio]/Microbiology and Parasitology, MESH: Genetic Vectors, Transduction, Genetic, Chromosome instability, MESH : Antigens, CD44, Drug Discovery, MESH : Female, MESH: Animals, Cells, Cultured, MESH: Lentivirus, Mice, Knockout, 0303 health sciences, B-Lymphocytes, Hematopoietic Stem Cell Transplantation, Nuclear Proteins, MESH : Interleukin-2 Receptor alpha Subunit, MESH: Transduction, Genetic, Flow Cytometry, MESH : Genetic Vectors, 3. Good health, Haematopoiesis, MESH : Lentivirus, [SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology, Hyaluronan Receptors, 030220 oncology & carcinogenesis, Knockout mouse, CD4 Antigens, [SDV.IMM]Life Sciences [q-bio]/Immunology, Molecular Medicine, Female, Stem cell, MESH : Gene Therapy, MESH: Cells, Cultured, MESH : Flow Cytometry, MESH : Male, CD8 Antigens, Genetic Vectors, MESH : Severe Combined Immunodeficiency, MESH: Severe Combined Immunodeficiency, MESH : Transduction, Genetic, Thymus Gland, Biology, MESH: Antigens, CD44, MESH : B-Lymphocytes, Viral vector, 03 medical and health sciences, MESH : Hematopoietic Stem Cell Transplantation, MESH: B-Lymphocytes, MESH : Mice, MESH : Cells, Cultured, Genetics, medicine, Animals, MESH : Thymus Gland, Molecular Biology, MESH: Mice, MESH: Hematopoietic Stem Cell Transplantation, 030304 developmental biology, MESH : T-Lymphocytes, Pharmacology, Severe combined immunodeficiency, MESH : Hematopoietic Stem Cells, Lentivirus, Interleukin-2 Receptor alpha Subunit, MESH : Nuclear Proteins, MESH: Thymus Gland, Genetic Therapy, medicine.disease, Endonucleases, Hematopoietic Stem Cells, MESH: Male, Transplantation, MESH: T-Lymphocytes, Immunology, Cancer research, MESH : Mice, Knockout, MESH : Antigens, CD4, Severe Combined Immunodeficiency, MESH : Animals, MESH : Antigens, CD3, MESH: Antigens, CD8, MESH: Gene Therapy, MESH : Antigens, CD8, MESH: Nuclear Proteins, MESH: Female

  6. 6

    المساهمون: Department of Molecular Medicine, Institut Pasteur, Fondation Cenci Bolognetti - Istituto Pasteur Italia, Fondazione Cenci Bolognetti, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome], Department of Immunology and Cell Biology, Research Center Borstel, Borstel, Germany, CNR - National Research Council of Italy, Institute of Molecular Biology and Pathology

    المصدر: European Journal of Immunology
    European Journal of Immunology, Wiley-VCH Verlag, 2012, 42 (5), pp.1129-39. ⟨10.1002/eji.201142019⟩

  7. 7

    المساهمون: Homéostasie Cellulaire et Pathologies (HCP), Université de Limoges (UNILIM)-CHU Limoges-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503), Service d'Immunologie et immunogénétique [CHU Limoges], CHU Limoges, Université de Limoges (UNILIM), Service de Chirurgie digestive, endocrinienne et générale [CHU Limoges]

    المصدر: Analytical Chemistry
    Analytical Chemistry, American Chemical Society, 2012, 84 (3), pp.1549-56. ⟨10.1021/ac202797z⟩

  8. 8

    المساهمون: Centre d'Immunologie de Marseille - Luminy (CIML), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU), Singapore Immunology Network (SIgN), Biomedical Sciences Institute (BMSI), Mount Sinai School of Medicine, Icahn School of Medicine at Mount Sinai [New York] (MSSM), Department of Gene and Cell Medicine [New York], Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: European Journal of Immunology
    European Journal of Immunology, Wiley-VCH Verlag, 2011, 41 (8), pp.2165-75. ⟨10.1002/eji.201141728⟩
    European Journal of Immunology, 2011, 41 (8), pp.2165-75. ⟨10.1002/eji.201141728⟩

  9. 9

    المؤلفون: Maxwell, C.A., Benitez, J., Gomez-Baldo, L., Osorio, A., Bonifaci, N., Fernandez-Ramires, R., Costes, S.V., Guino, E., Chen, H., Evans, G.J.R., Mohan, P., Catala, I., Petit, A., Aguilar, H., Villanueva, A., Aytes, A., Serra-Musach, J., Rennert, G., Lejbkowicz, F., Peterlongo, P., Manoukian, S., Peissel, B., Ripamonti, C.B., Bonanni, B., Viel, A., Allavena, A., Bernard, L., Radice, P., Friedman, E., Kaufman, B., Laitman, Y., Dubrovsky, M., Milgrom, R., Jakubowska, A., Cybulski, C., Gorski, B., Jaworska, K., Durda, K., Sukiennicki, G., Lubinski, J., Shugart, Y.Y., Domchek, S.M., Letrero, R., Weber, B.L., Hogervorst, F.B.L., Rookus, M.A., Collee, J.M., Devilee, P., Ligtenberg, M.J., Luijt, R.B. van der, Aalfs, C.M., Waisfisz, Q., Wijnen, J., Roozendaal, C.E.P. van, Easton, D.F., Peock, S., Cook, M., Oliver, C., Frost, D., Harrington, P., Evans, D.G., Lalloo, F., Eeles, R., Izatt, L., Chu, C., Eccles, D., Douglas, F., Brewer, C., Nevanlinna, H., Heikkinen, T., Couch, F.J., Lindor, N.M., Wang, X.S., Godwin, A.K., Caligo, M.A., Lombardi, G., Loman, N., Karlsson, P., Ehrencrona, H., Wachenfeldt, A. von, Barkardottir, R.B., Hamann, U., Rashid, M.U., Lasa, A., Caldes, T., Andres, R., Schmitt, M., Assmann, V., Stevens, K., Offit, K., Curado, J., Tilgner, H., Guigo, R., Aiza, G., Brunet, J., Castellsague, J., Martrat, G., Urruticoechea, A., Blanco, I., Tihomirova, L., Goldgar, D.E., Buys, S., John, E.M., Miron, A., Southey, M., Daly, M.B., Schmutzler, R.K., Wappenschmidt, B., Meindl, A., Arnold, N., Deissler, H., Varon-Mateeva, R., Sutter, C., Niederacher, D., Imyamitov, E., Sinilnikova, O.M., Stoppa-Lyonne, D., Mazoyer, S., Verny-Pierre, C., Castera, L., Pauw, A. de, Bignon, Y.J., Uhrhammer, N., Peyrat, J.P., Vennin, P., Ferrer, S.F., Collonge-Rame, M.A., Mortemousque, I., Spurdle, A.B., Beesley, J., Chen, X.Q., Healey, S., Barcellos-Hoff, M.H., Vidal, M., Gruber, S.B., Lazaro, C., Capella, G., McGuffog, L., Nathanson, K.L., Antoniou, A.C., Chenevix-Trench, G., Fleisch, M.C., Moreno, V., Pujana, M.A., HEBON, EMBRACE, SWE-BRCA, BCFR, GEMO Study Collaborators, kConFab

    المساهمون: Human genetics, CCA - Innovative therapy, Universitat de Barcelona, Faculteit der Geneeskunde, Translational Research Laboratory, Catalan Institute of Oncology-Bellvitge Institute for Biomedical Research, Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Catalan Institute of Oncology, Human Genetics Group, Spanish National Cancer Research Centre, Biomedical Research Centre Network for Rare Diseases, CIBER de Enfermedades Raras (CIBERER), Biomarkers and Susceptibility Unit, Life Science Division [LBNL Berkeley], Lawrence Berkeley National Laboratory [Berkeley] (LBNL), Child and Family Research Institute, Department of Pathology, University Hospital of Bellvitge, Department of Community Medicine and Epidemiology, CHS National Cancer Control Center, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Fondazione IRCCS Istituto Nazionale Tumouri (INT)-Fondazione Istituto FIRC di Oncologia Molecolare, Unit of Medical Genetics, Fondazione IRCCS Istituto Nazionale Tumouri (INT), Division of Cancer Prevention and Genetics, Unit of Experimental Oncology 1, Centro di Riferimento Oncologico, Department of Genetics, Biology and Biochemistry, University of Turin, Department of Experimental Oncology, Istituto Europeo di Oncologia-Consortium for Genomics Technology (Cogentech), The Susanne Levy Gertner Oncogenetics Unit, Institute of Human Genetics, Sackler Faculty of Medicine, Tel Aviv University [Tel Aviv], Department of Genetics and Pathology, Pomeranian Medical University-International Hereditary Cancer Centre, Unit of Statistical Genetics, National Institutes of Health [Bethesda] (NIH)-National Institute of Mental Health, Abramson Cancer Center, University of Pennsylvania [Philadelphia], Family Cancer Clinic, Netherlands Cancer Institute, Department of Epidemiology, Department of Clinical Genetics, Erasmus University Medical Center [Rotterdam] (Erasmus MC)-Family Cancer Clinic, Department of Genetic Epidemiology, Leiden University Medical Center (LUMC), Department of Human Genetics, Radboud university [Nijmegen], Department of Clinical Molecular Genetics, University Medical Center [Utrecht], Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA)-University of Amsterdam [Amsterdam] (UvA), VU University Medical Center [Amsterdam], Center for Human and Clinical Genetics, Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht]-Maastricht University [Maastricht], Centre for Cancer Genetic Epidemiology, University of Cambridge [UK] (CAM), Department of Oncology, Genetic Medicine, Manchester Academic Health Sciences Centre-Central Manchester University Hospitals, Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, Yorkshire Regional Genetics Service, St James's hospital, Wessex Clinical Genetics Service, Princess Anne Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Royal Devon & Exeter Hospital, Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Department of Laboratory Medicine and Pathology, Mayo Clinic, Department of Medical Genetics, Department of Pathology and Laboratory Medicine, University of Kansas Medical Center [Lawrence], Section of Genetic Oncology, Pisa University Hospital-University of Pisa - Università di Pisa, Lund University Hospital, Sahlgrenska University Hospital [Gothenburg], Departament of Genetics and Pathology, Uppsala University-Rudbeck Laboratory, Karolinska University Hospital [Stockholm], Landspitali-University Hospital, Molecular Genetics of Breast Cancer, German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Deutsches Krebsforschungszentrum, Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Servicio de Genética, Hospital de la Santa Creu i Sant Pau, Molecular Oncology Laboratory, Hospital Clínico San Carlos, Medical Oncology Division, Hospital Clínico de Zaragoza, Department of Internal Medicine III, University of Rostock, Center for Experimental Medicine, Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE)-Institute of Tumor Biology, University of Michigan [Ann Arbor], University of Michigan System-University of Michigan System, Clinical Genetics Service, Memorial Sloane Kettering Cancer Center [New York], Bioinformatics and Genomics Group, Centre for Genomic Regulation (CRG), Genetic Counseling and Hereditary Cancer Programme, Latvian Biomedical Research and Study Centre [Rīga], Department of Dermatology, University of Utah School of Medicine [Salt Lake City], Department of Internal Medicine, Huntsman Cancer Institute, Cancer Prevention Institute of California, Department of Cancer Biology, Dana-Farber Cancer Institute [Boston], Department of Surgery, Harvard Medical School [Boston] (HMS), entre for Molecular, Environmental, Genetic and Analytic (MEGA) Epidemiology, University of Melbourne, Division of Population Science, Fox Chase Cancer Center, Department of Gynaecology and Obstetrics, University Hospital of Cologne [Cologne]-Centre of Familial Breast and Ovarian Cancer-Centre for Integrated Oncology (CIO), Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), University Hospital of Schleswig-Holstein-Christian-Albrechts-Universität zu Kiel (CAU), Universitätsklinikum Ulm - University Hospital of Ulm, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Heidelberg University Hospital [Heidelberg], University Hospital Düsseldorf-Heinrich Heine Universität Düsseldorf = Heinrich Heine University [Düsseldorf], N. N. Petrov Institute of Oncology, Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Centre Léon Bérard [Lyon]-Hospices Civils de Lyon (HCL), Génétique moléculaire, signalisation et cancer (GMSC), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Pathologie moléculaire des cancers, Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Département d'Oncogénétique, Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), UNICANCER-UNICANCER, Laboratoire d'Oncologie Moléculaire Humaine, Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université Lille Nord de France (COMUE)-UNICANCER-Université Lille Nord de France (COMUE)-UNICANCER, Consultation d'Oncogénétique, Laboratoire de Génétique Chromosomique, Hôtel-Dieu-CH Chambéry, Département de Génétique et Reproduction, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon)-Hôpital Saint-Jacques, Service de génétique [Tours], Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau, Queensland Institute of Medical Research, Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute [Boston]-Department of Cancer Biology, Department of Genetics [Boston], Department of Internal Medicine, Epidemiology, Human Genetics, Department of Obstetrics and Gynaecologie, Heinrich Heine Universität Düsseldorf = Heinrich Heine University [Düsseldorf], This work was funded by the Spanish Ministries of Health, and Science ane Innovation (CB07/02/2005, FIS 08/1120, 08/1359, 08/1635, and 09/02483, RTICCC RD06/0020/1060 and RD06/0020/0028, Transversal Action Against Cancer, the Spanish Biomedical Research Centre Networks for Epidemiology and Public Health, and Rare Diseases, and the 'Ramón y Cajal' Young Investigator Program), the Spanish National Society of Medical Oncology (2010), the Spanish Association Against Cancer (AECC 2010), the AGAUR Catalan Government Agency (2009SGR1489 and 2009SGR293, and the Beatriu Pinós Postdoctoral Program), the Ramón Areces Foundation (XV), the 'Roses Contra el Càncer' Foundation, the Michael Cuccione Foundation for Childhood Cancer Research, Cancer Research-UK (C490/A10119, C1287/A8874, C1287/A10118, C5047/A8385, and C8197/A10123), the National Institute for Health Research (UK), the Association for International Cancer Research (AICR-07-0454), the Ligue National Contre le Cancer (France), the Association 'Le cancer du sein, parlons-en!', the Dutch Cancer Society (NKI 1998-1854, 2004-3088, and 2007-3756), the Fondazione Italiana per la Ricerca sul Cancro ('Hereditary Tumors'), the Associazione Italiana per la Ricerca sul Cancro (4017), the Italian Ministero della Salute (RFPS-2006-3-340203 and 'Progetto Tumori Femminili'), the Italian Ministero dell'Universita' e Ricerca (RBLAO3-BETH), the Fondazione IRCCS Istituto Nazionale Tumori (INT '5×1000'), the Fondazione Cassa di Risparmio di Pisa (Istituto Toscano Tumori), the National Breast Cancer Foundation (Australia), the Australian National Health and Medical Research Council (145684, 288704, and 454508), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, the Cancer Foundation of Western Australia, the German Cancer Aid (107054), the Center for Molecular Medicine Cologne (TV93), the National Cancer Institute (USA, CA128978 and CA122340), National Institutes of Health (RFA-CA-06-503, BCFR U01 CA69398, CA69417, CA69446, CA69467, CA69631, and CA69638), the Research Triangle Institute Informatics Support Center (RFP N02PC45022-46), the Specialized Program of Research Excellence (SPORE P50 CA83638 and CA113916), the Department of Defense Breast Cancer Research Program (05/0612), the Eileen Stein Jacoby Fund, the Breast Cancer Research Foundation, the Marianne and Robert MacDonald Foundation, the Komen Foundation, the Helsinki University Central Hospital Research Fund, the Academy of Finland (110663), the Finnish Cancer Society, the Sigrid Juselius Foundation, and the EU FP7 (223175, HEALTH-F2-2009-223175)., HEBON, EMBRACE, SWE-BRCA, BCFR, GEMO Study Collaborators, kConFab, Human Genetics, Genetica & Celbiologie, RS: GROW - School for Oncology and Reproduction, Hôpital Bretonneau-Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Università degli studi di Torino = University of Turin (UNITO), Tel Aviv University (TAU), International Hereditary Cancer Centre-Pomeranian Medical University [Szczecin] (PUM), University of Pennsylvania, Universiteit Leiden-Universiteit Leiden, Radboud University [Nijmegen], University of Kansas Medical Center [Kansas City, KS, USA], Uppsala University, Université de Lille-UNICANCER-Université de Lille-UNICANCER, Autard, Delphine, Neurology, Pathology

    المصدر: Dipòsit Digital de la UB
    Universidad de Barcelona
    PloS Biology, 9(11):e1001199. Public Library of Science
    PLoS Biology; 9(11) (2011)
    Recercat. Dipósit de la Recerca de Catalunya
    instname
    PLoS Biology
    PLoS Biology, 9(11)
    PLoS Biology, 9(11):e1001199. Public Library of Science
    PLoS Biology, Public Library of Science, 2011, 9 (11), pp.e1001199. ⟨10.1371/journal.pbio.1001199⟩
    PLoS biology, 9(11). Public Library of Science
    Maxwell, C A, Benitez, J, Gomez-Baldo, L, Osorio, A, Bonifaci, N, Fernandez-Ramires, R, Costes, S V, Guino, E, Chen, H, Evans, G J R, Mohan, P, Catala, I, Petit, A, Aguilar, H, Villanueva, A, Aytes, A, Serra-Musach, J, Rennert, G, Lejbkowicz, F, Peterlongo, P, Manoukian, S, Peissel, B, Ripamonti, C B, Bonanni, B, Viel, A, Allavena, A, Bernard, L, Radice, P, Friedman, E, Kaufman, B, Laitman, Y, Dubrovsky, M, Milgrom, R, Jakubowska, A, Cybulski, C, Gorski, B, Jaworska, K, Durda, K, Sukiennicki, G, Lubinski, J, Shugart, Y Y, Domchek, S M, Letrero, R, Weber, B L, Hogervorst, F B L, Rookus, M A, Collee, J M, Devilee, P, Ligtenberg, M J, van der Luijt, R B, Aalfs, C M, Waisfisz, Q, van Wijnen, J, van Roozendaal, C E P, Easton, D F, Peock, S, Cook, M, Oliver, C, Frost, D, Harrington, P, Evans, D G, Lalloo, F, Eeles, R, Izatt, L, Chu, C, Eccles, D, Douglas, F, Brewer, C, Nevanlinna, H, Heikkinen, T, Couch, F J, Lindor, N M, Wang, X S, Godwin, A K, Caligo, M A, Lombardi, G, Loman, N, Karlsson, P, Ehrencrona, H, von Wachenfeldt, A, Barkardottir, R B, Hamann, U, Rashid, M U, Lasa, A, Caldes, T, Andres, R, Schmitt, M, Assmann, V, Stevens, K, Offit, K, Curado, J, Tilgner, H, Guigo, R, Aiza, G, Brunet, J, Castellsague, J, Martrat, G, Urruticoechea, A & Blanco, I 2011, ' Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer ', PloS Biology, vol. 9, no. 11, e1001199 . https://doi.org/10.1371/journal.pbio.1001199
    PLoS Biology; Vol 9
    Plos Biology, 9(11):e1001199. Public Library of Science
    PLoS Biology, 2011, 9 (11), pp.e1001199. ⟨10.1371/journal.pbio.1001199⟩
    PLOS BIOLOGY
    r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
    PLoS Biology, Vol 9, Iss 11, p e1001199 (2011)
    PLoS Biology (print), 9(11). Public Library of Science

    مصطلحات موضوعية: Mama -- Càncer -- Aspectes genètics, MESH: Extracellular Matrix Proteins, endocrine system diseases, Cellular differentiation, Genes, BRCA2, Genes, BRCA1, Microtubules, MESH: Genotype, 0302 clinical medicine, Breast cancer, Aurora Kinases, MESH: Genetic Variation, Biology (General), skin and connective tissue diseases, 0303 health sciences, Extracellular Matrix Proteins, Tumor, MESH: Microtubules, Cancer Risk Factors, 3. Good health, Hyaluronan Receptors, Oncology, Receptors, Estrogen, MESH: Epithelial Cells, 030220 oncology & carcinogenesis, MESH: Receptors, Estrogen, Medicine, General Agricultural and Biological Sciences, Genotype, QH301-705.5, MESH: Antigens, CD44, General Biochemistry, Genetics and Molecular Biology, MESH: Protein-Serine-Threonine Kinases, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, SDG 3 - Good Health and Well-being, Genetics, Cancer Genetics, Humans, Progenitor cell, Biology, MESH: BRCA1 Protein, MESH: Humans, CD44, Genetic Variation, Epithelial Cells, Oncogenes, medicine.disease, BRCA1, BRCA2, Genes, Carcinogenesis, MESH: Genes, BRCA1, MESH: Female, MESH: Genes, BRCA2, Population Genetics, HeLa Cells, Epithelial cells, medicine.disease_cause, MESH: BRCA2 Protein, Cell polarity, Basic Cancer Research, Receptors, Breast, MESH: Breast, MESH: Heterozygote, Aurora Kinase A, Cèl·lules epitelials, biology, BRCA1 Protein, General Neuroscience, MESH: Genetic Predisposition to Disease, Cell Polarity, Biological Sciences, BRCA2 Protein, Mama -- Càncer -- Aspectes moleculars, Protein-Serine-Threonine Kinases, Female, Stem cell, MESH: Cell Polarity, Research Article, Oncogens, Heterozygote, MESH: Cell Line, Tumor, [SDV.CAN]Life Sciences [q-bio]/Cancer, Breast Neoplasms, Protein Serine-Threonine Kinases, Cell Line, Càncer de mama, Cell Line, Tumor, Regulació genètica, medicine, Genetic Predisposition to Disease, Antigens, 030304 developmental biology, General Immunology and Microbiology, Human Genetics, Estrogen, MESH: HeLa Cells, Genetics of Disease, biology.protein, Cancer research, Gene Function, MESH: Breast Neoplasms

    وصف الملف: application/pdf; text

  10. 10

    المؤلفون: Benedita Rocha, Antonio A. Freitas

    المساهمون: Dynamiques Lymphocytaires, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Institut Necker Enfants-Malades (INEM - UM 111 (UMR 8253 / U1151)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique ( CNRS ), Institut Necker Enfants-Malades (INEM) ( INEM - UM 111 (UMR 8253 / U1151) ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Centre National de la Recherche Scientifique ( CNRS ), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Current Opinion in Immunology
    Current Opinion in Immunology, Elsevier, 1999, 11 (2), pp.152-6. ⟨10.1016/S0952-7915(99)80026-0⟩
    Current Opinion in Immunology, Elsevier, 1999, 11 (2), pp.152-6
    Current Opinion in Immunology, 1999, 11 (2), pp.152-6. ⟨10.1016/S0952-7915(99)80026-0⟩